[1] 中华人民共和国卫生部.卫生部介绍中国艾滋病疫情现状[R/OL].北京:中华人民共和国卫生部2009.Available at URL: http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s3582/200911/44754.htm.
[2] Vissers DC,Voeten HA,Nagelkerke NJ,et al.The impact of pre-exposure prophylaxis(PrEP)on HIV epidemics in Africa and India: a simulation study[J].PLoS One,2008,3(5):e2077.
[3] Youle M,Wainberg MA.Pre-exposure chemoprophylaxis(PREP)as an HIV prevention strategy[J].J Int Assoc Physic AIDS Care,2003,2(3):102-105.
[4] 钱跃升,傅继华,张晓菲,等.男男性接触者人群艾滋病防治相关信息定性研究[J].现代预防医学,2007,34(17):3281-3285.
[5] 冯楠,吕繁,曾刚,等.四川省凉山地区彝族男青年对包皮环切可接受性及影响因素分析[J].中华流行病学杂志,2010,31(3):281-285.
[6] Mattson CL,Bailey RC,Muga R,et al.Acceptability of male circumcision and predictors of circumcision preference among men and women in Nyanza Province,Kenya[J].AIDS Care,2005,17(2):182-194.
[7] Lagarde E,Dirk T,Puren A,et al.Acceptability of male circumcision as a tool for preventing HIV infection in a highly infected community in South Africa[J].AIDS,2003,17(1):89-95.
[8] Rain-Taljaard RC,Lagarde E,Taljaard DJ,et al.Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection[J].AIDS Care,2003,15(3):315-327.
[9] Weiss HA,Halperin D,Bailey RC,et al.Male circumcision for HIV prevention: from evidence to action?[J].AIDS,2008,22(5):567-574.
[10] Westercamp N,Bailey RC.Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review[J].AIDS Behav,2007,11(3):341-355.
[11] 王芸,蒋岩.杀微生物剂的可接受性与影响因素及其在中国的应用前景[J].中国艾滋病性病,2008,14(3):317-321.
[12] Carballo-Dieguez A,Stein Z,Saez H,et al.Frequent use of lubricants for anal sex among men who have sex with men: the HIV prevention potential of a microbicidal gel[J].Am J Public Health,2000,90(7):1117-1121.
[13] Carballo-Dieguez A,Dolezal C,Bauermeister JA,et al.Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised,crossover acceptability trial among men who have sex with men[J].Sex Transm Infect,2008,84(6):483-487.
[14] Chen MY,Millwood IY,Wand H,et al.A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis[J].J Acquir Immune Defic Syndr,2009,50(4):375-380.
[15] Lee SJ,Brooks RA,Newman PA,et al.HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach[J].AIDS Care,2008,20(10):1161-1168.
[16] Brooks RA,Newman PA,Duan N,et al.HIV vaccine trial preparedness among Spanish-speaking Latinos in the US[J].AIDS Care,2007,19(1):52-58.
[17] Newman PA,Duan N,Lee SJ,et al.HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics[J].Vaccine,2006,24(12):2094-2101.
[18] Suraratdecha C,Ainsworth M,Tangcharoensathien V,et al.The private demand for an AIDS vaccine in Thailand[J].Health Policy,2005,71(3):271-287.
[19] Mimiaga MJ,Case P,Johnson CV,et al.Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education[J].J Acquir Immune Defic Syndr,2009,50(1):77-83.
[20] Liu AY,Kittredge PV,Vittinghoff E,et al.Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men[J].J Acquir Immune Defic Syndr,2008,47(2):241-247.
[21] Nodin N,Carballo-Dieguez A,Ventuneac AM,et al.Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback[J].AIDS Care,2008,20(1):106-115.
[22] Kellerman SE,Hutchinson AB,Begley EB,et al.Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events,2004[J].J Acquir Immune Defic Syndr,2006,43(3):376-377.
[23] 姜晓梅,吕繁.暴露前药物预防:预防HIV感染的潜在新策略[J].疾病控制杂志,2008,12(2):159-163.